ARKF vs IBB
ARK Fintech Innovation ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.75% for ARKF.
- • IBB pays a higher dividend yield (0.16%).
Side-by-side metrics
| Metric | ARKF | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.10% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $727M | $11.50B |
YTD return | -10.29% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.12 | 0.60 |
P/E ratio | 30.33 | 25.48 |
Last price | $42.90 | $217.75 |
Inception | — | — |
Issuer | ARK | iShares |
ARKF top holdings
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 9.06% |
| XYZ | Block Inc Class A | 8.15% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 6.18% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 5.30% |
| HOOD | Robinhood Markets Inc Class A | 4.78% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 4.62% |
| META | Meta Platforms Inc Class A | 4.55% |
| TOST | Toast Inc Class A | 4.20% |
| AMZN | Amazon.com Inc | 3.80% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services. Managed by ARK, the fund carries $727M in assets under management, an expense ratio of 0.75%, a dividend yield of 0.10%. Its largest holding is Shopify Inc Registered Shs -A- Subord Vtg (SHOP), which represents 9.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.7%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.